Expert Guidance in Advanced NSCLC: Selection of First-line and Maintenance Therapy

The overall goal of this initiative, which will be jointly sponsored by USF Health and Clinical Care Options (CCO), is to continue to close professional practice gaps associated with the first-line treatment of non-small-cell lung cancer (NSCLC) among clinicians outside of the United States and to provide guidance on standards of optimal individualized treatment of the disease in the first-line setting. The primary objectives the joint sponsors will use to accomplish this goal are:

1.expand upon a current continuing education program designed to address these practice gaps
2.provide an online tool that is easy to access and use that promotes the application of the latest developments in optimal care of NSCLC
3.measure the educational outcomes associated with this effort
4.publish this data for a wider audience